Global Transthyretin Amyloidosis Treatment Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The growth is attributed to the extensive research in the development of new therapies and the presence of robust pipeline drugs that are used to treat transthyretin.
The global market for Transthyretin Amyloidosis Treatment is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Transthyretin Amyloidosis Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Transthyretin Amyloidosis Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Transthyretin Amyloidosis Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Transthyretin Amyloidosis Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Transthyretin Amyloidosis Treatment players cover Pfizer Inc., Johnson & Johnson Services, Inc., Ionis Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc. and BridgeBio Pharma, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Transthyretin Amyloidosis Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Transthyretin Amyloidosis Treatment market, with both quantitative and qualitative data, to help readers understand how the Transthyretin Amyloidosis Treatment market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Transthyretin Amyloidosis Treatment market and forecasts the market size by Type (ATTR-PN and ATTR-CM,), by Application (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies and Online Pharmacies), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Transthyretin Amyloidosis Treatment, Research Methodology, etc.
Chapter 2: Executive Summary, global Transthyretin Amyloidosis Treatment market size and CAGR, Transthyretin Amyloidosis Treatment market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Transthyretin Amyloidosis Treatment revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Transthyretin Amyloidosis Treatment revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Transthyretin Amyloidosis Treatment market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Pfizer Inc., Johnson & Johnson Services, Inc., Ionis Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., BridgeBio Pharma, Inc., Bristol-Myers Squibb Company, Acrotech Biopharma, AstraZeneca and Astellas Pharma, Inc., etc.
Chapter 14: Research Findings and Conclusion
The growth is attributed to the extensive research in the development of new therapies and the presence of robust pipeline drugs that are used to treat transthyretin.
The global market for Transthyretin Amyloidosis Treatment is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Transthyretin Amyloidosis Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Transthyretin Amyloidosis Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Transthyretin Amyloidosis Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Transthyretin Amyloidosis Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Transthyretin Amyloidosis Treatment players cover Pfizer Inc., Johnson & Johnson Services, Inc., Ionis Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc. and BridgeBio Pharma, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Transthyretin Amyloidosis Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Transthyretin Amyloidosis Treatment market, with both quantitative and qualitative data, to help readers understand how the Transthyretin Amyloidosis Treatment market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Transthyretin Amyloidosis Treatment market and forecasts the market size by Type (ATTR-PN and ATTR-CM,), by Application (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies and Online Pharmacies), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- ATTR-PN
- ATTR-CM
- Hospital Pharmacies
- Specialty Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Ionis Pharmaceuticals, Inc.
- Alnylam Pharmaceuticals, Inc.
- BridgeBio Pharma, Inc.
- Bristol-Myers Squibb Company
- Acrotech Biopharma
- AstraZeneca
- Astellas Pharma, Inc.
- Prothena
- SOM Biotech
Chapter 1: Scope of Transthyretin Amyloidosis Treatment, Research Methodology, etc.
Chapter 2: Executive Summary, global Transthyretin Amyloidosis Treatment market size and CAGR, Transthyretin Amyloidosis Treatment market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Transthyretin Amyloidosis Treatment revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Transthyretin Amyloidosis Treatment revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Transthyretin Amyloidosis Treatment market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Pfizer Inc., Johnson & Johnson Services, Inc., Ionis Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., BridgeBio Pharma, Inc., Bristol-Myers Squibb Company, Acrotech Biopharma, AstraZeneca and Astellas Pharma, Inc., etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Transthyretin Amyloidosis Treatment Market Size 2017-2028
2.1.2 Transthyretin Amyloidosis Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Transthyretin Amyloidosis Treatment Segment by Type
2.2.1 ATTR-PN
2.2.2 ATTR-CM
2.3 Transthyretin Amyloidosis Treatment Market Size by Type
2.3.1 Transthyretin Amyloidosis Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Transthyretin Amyloidosis Treatment Market Size Market Share by Type (2017-2022)
2.4 Transthyretin Amyloidosis Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Specialty Pharmacies
2.4.3 Retail Pharmacies
2.4.4 Online Pharmacies
2.5 Transthyretin Amyloidosis Treatment Market Size by Application
2.5.1 Transthyretin Amyloidosis Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Transthyretin Amyloidosis Treatment Market Size Market Share by Application (2017-2022)
3 TRANSTHYRETIN AMYLOIDOSIS TREATMENT MARKET SIZE BY PLAYER
3.1 Transthyretin Amyloidosis Treatment Market Size Market Share by Players
3.1.1 Global Transthyretin Amyloidosis Treatment Revenue by Players (2020-2022)
3.1.2 Global Transthyretin Amyloidosis Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Transthyretin Amyloidosis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TRANSTHYRETIN AMYLOIDOSIS TREATMENT BY REGIONS
4.1 Transthyretin Amyloidosis Treatment Market Size by Regions (2017-2022)
4.2 Americas Transthyretin Amyloidosis Treatment Market Size Growth (2017-2022)
4.3 APAC Transthyretin Amyloidosis Treatment Market Size Growth (2017-2022)
4.4 Europe Transthyretin Amyloidosis Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Transthyretin Amyloidosis Treatment Market Size by Country (2017-2022)
5.2 Americas Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022)
5.3 Americas Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transthyretin Amyloidosis Treatment Market Size by Region (2017-2022)
6.2 APAC Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022)
6.3 APAC Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Transthyretin Amyloidosis Treatment by Country (2017-2022)
7.2 Europe Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022)
7.3 Europe Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Transthyretin Amyloidosis Treatment by Region (2017-2022)
8.2 Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TRANSTHYRETIN AMYLOIDOSIS TREATMENT MARKET FORECAST
10.1 Global Transthyretin Amyloidosis Treatment Forecast by Regions (2023-2028)
10.1.1 Global Transthyretin Amyloidosis Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Transthyretin Amyloidosis Treatment Forecast
10.1.3 APAC Transthyretin Amyloidosis Treatment Forecast
10.1.4 Europe Transthyretin Amyloidosis Treatment Forecast
10.1.5 Middle East & Africa Transthyretin Amyloidosis Treatment Forecast
10.2 Americas Transthyretin Amyloidosis Treatment Forecast by Country (2023-2028)
10.2.1 United States Transthyretin Amyloidosis Treatment Market Forecast
10.2.2 Canada Transthyretin Amyloidosis Treatment Market Forecast
10.2.3 Mexico Transthyretin Amyloidosis Treatment Market Forecast
10.2.4 Brazil Transthyretin Amyloidosis Treatment Market Forecast
10.3 APAC Transthyretin Amyloidosis Treatment Forecast by Region (2023-2028)
10.3.1 China Transthyretin Amyloidosis Treatment Market Forecast
10.3.2 Japan Transthyretin Amyloidosis Treatment Market Forecast
10.3.3 Korea Transthyretin Amyloidosis Treatment Market Forecast
10.3.4 Southeast Asia Transthyretin Amyloidosis Treatment Market Forecast
10.3.5 India Transthyretin Amyloidosis Treatment Market Forecast
10.3.6 Australia Transthyretin Amyloidosis Treatment Market Forecast
10.4 Europe Transthyretin Amyloidosis Treatment Forecast by Country (2023-2028)
10.4.1 Germany Transthyretin Amyloidosis Treatment Market Forecast
10.4.2 France Transthyretin Amyloidosis Treatment Market Forecast
10.4.3 UK Transthyretin Amyloidosis Treatment Market Forecast
10.4.4 Italy Transthyretin Amyloidosis Treatment Market Forecast
10.4.5 Russia Transthyretin Amyloidosis Treatment Market Forecast
10.5 Middle East & Africa Transthyretin Amyloidosis Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Transthyretin Amyloidosis Treatment Market Forecast
10.5.2 South Africa Transthyretin Amyloidosis Treatment Market Forecast
10.5.3 Israel Transthyretin Amyloidosis Treatment Market Forecast
10.5.4 Turkey Transthyretin Amyloidosis Treatment Market Forecast
10.5.5 GCC Countries Transthyretin Amyloidosis Treatment Market Forecast
10.6 Global Transthyretin Amyloidosis Treatment Forecast by Type (2023-2028)
10.7 Global Transthyretin Amyloidosis Treatment Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Information
11.1.2 Pfizer Inc. Transthyretin Amyloidosis Treatment Product Offered
11.1.3 Pfizer Inc. Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc. Latest Developments
11.2 Johnson & Johnson Services, Inc.
11.2.1 Johnson & Johnson Services, Inc. Company Information
11.2.2 Johnson & Johnson Services, Inc. Transthyretin Amyloidosis Treatment Product Offered
11.2.3 Johnson & Johnson Services, Inc. Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Johnson & Johnson Services, Inc. Main Business Overview
11.2.5 Johnson & Johnson Services, Inc. Latest Developments
11.3 Ionis Pharmaceuticals, Inc.
11.3.1 Ionis Pharmaceuticals, Inc. Company Information
11.3.2 Ionis Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Product Offered
11.3.3 Ionis Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Ionis Pharmaceuticals, Inc. Main Business Overview
11.3.5 Ionis Pharmaceuticals, Inc. Latest Developments
11.4 Alnylam Pharmaceuticals, Inc.
11.4.1 Alnylam Pharmaceuticals, Inc. Company Information
11.4.2 Alnylam Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Product Offered
11.4.3 Alnylam Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Alnylam Pharmaceuticals, Inc. Main Business Overview
11.4.5 Alnylam Pharmaceuticals, Inc. Latest Developments
11.5 BridgeBio Pharma, Inc.
11.5.1 BridgeBio Pharma, Inc. Company Information
11.5.2 BridgeBio Pharma, Inc. Transthyretin Amyloidosis Treatment Product Offered
11.5.3 BridgeBio Pharma, Inc. Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 BridgeBio Pharma, Inc. Main Business Overview
11.5.5 BridgeBio Pharma, Inc. Latest Developments
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Information
11.6.2 Bristol-Myers Squibb Company Transthyretin Amyloidosis Treatment Product Offered
11.6.3 Bristol-Myers Squibb Company Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bristol-Myers Squibb Company Main Business Overview
11.6.5 Bristol-Myers Squibb Company Latest Developments
11.7 Acrotech Biopharma
11.7.1 Acrotech Biopharma Company Information
11.7.2 Acrotech Biopharma Transthyretin Amyloidosis Treatment Product Offered
11.7.3 Acrotech Biopharma Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Acrotech Biopharma Main Business Overview
11.7.5 Acrotech Biopharma Latest Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Transthyretin Amyloidosis Treatment Product Offered
11.8.3 AstraZeneca Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 AstraZeneca Main Business Overview
11.8.5 AstraZeneca Latest Developments
11.9 Astellas Pharma, Inc.
11.9.1 Astellas Pharma, Inc. Company Information
11.9.2 Astellas Pharma, Inc. Transthyretin Amyloidosis Treatment Product Offered
11.9.3 Astellas Pharma, Inc. Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Astellas Pharma, Inc. Main Business Overview
11.9.5 Astellas Pharma, Inc. Latest Developments
11.10 Prothena
11.10.1 Prothena Company Information
11.10.2 Prothena Transthyretin Amyloidosis Treatment Product Offered
11.10.3 Prothena Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Prothena Main Business Overview
11.10.5 Prothena Latest Developments
11.11 SOM Biotech
11.11.1 SOM Biotech Company Information
11.11.2 SOM Biotech Transthyretin Amyloidosis Treatment Product Offered
11.11.3 SOM Biotech Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 SOM Biotech Main Business Overview
11.11.5 SOM Biotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Transthyretin Amyloidosis Treatment Market Size 2017-2028
2.1.2 Transthyretin Amyloidosis Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Transthyretin Amyloidosis Treatment Segment by Type
2.2.1 ATTR-PN
2.2.2 ATTR-CM
2.3 Transthyretin Amyloidosis Treatment Market Size by Type
2.3.1 Transthyretin Amyloidosis Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Transthyretin Amyloidosis Treatment Market Size Market Share by Type (2017-2022)
2.4 Transthyretin Amyloidosis Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Specialty Pharmacies
2.4.3 Retail Pharmacies
2.4.4 Online Pharmacies
2.5 Transthyretin Amyloidosis Treatment Market Size by Application
2.5.1 Transthyretin Amyloidosis Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Transthyretin Amyloidosis Treatment Market Size Market Share by Application (2017-2022)
3 TRANSTHYRETIN AMYLOIDOSIS TREATMENT MARKET SIZE BY PLAYER
3.1 Transthyretin Amyloidosis Treatment Market Size Market Share by Players
3.1.1 Global Transthyretin Amyloidosis Treatment Revenue by Players (2020-2022)
3.1.2 Global Transthyretin Amyloidosis Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Transthyretin Amyloidosis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TRANSTHYRETIN AMYLOIDOSIS TREATMENT BY REGIONS
4.1 Transthyretin Amyloidosis Treatment Market Size by Regions (2017-2022)
4.2 Americas Transthyretin Amyloidosis Treatment Market Size Growth (2017-2022)
4.3 APAC Transthyretin Amyloidosis Treatment Market Size Growth (2017-2022)
4.4 Europe Transthyretin Amyloidosis Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Transthyretin Amyloidosis Treatment Market Size by Country (2017-2022)
5.2 Americas Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022)
5.3 Americas Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transthyretin Amyloidosis Treatment Market Size by Region (2017-2022)
6.2 APAC Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022)
6.3 APAC Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Transthyretin Amyloidosis Treatment by Country (2017-2022)
7.2 Europe Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022)
7.3 Europe Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Transthyretin Amyloidosis Treatment by Region (2017-2022)
8.2 Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TRANSTHYRETIN AMYLOIDOSIS TREATMENT MARKET FORECAST
10.1 Global Transthyretin Amyloidosis Treatment Forecast by Regions (2023-2028)
10.1.1 Global Transthyretin Amyloidosis Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Transthyretin Amyloidosis Treatment Forecast
10.1.3 APAC Transthyretin Amyloidosis Treatment Forecast
10.1.4 Europe Transthyretin Amyloidosis Treatment Forecast
10.1.5 Middle East & Africa Transthyretin Amyloidosis Treatment Forecast
10.2 Americas Transthyretin Amyloidosis Treatment Forecast by Country (2023-2028)
10.2.1 United States Transthyretin Amyloidosis Treatment Market Forecast
10.2.2 Canada Transthyretin Amyloidosis Treatment Market Forecast
10.2.3 Mexico Transthyretin Amyloidosis Treatment Market Forecast
10.2.4 Brazil Transthyretin Amyloidosis Treatment Market Forecast
10.3 APAC Transthyretin Amyloidosis Treatment Forecast by Region (2023-2028)
10.3.1 China Transthyretin Amyloidosis Treatment Market Forecast
10.3.2 Japan Transthyretin Amyloidosis Treatment Market Forecast
10.3.3 Korea Transthyretin Amyloidosis Treatment Market Forecast
10.3.4 Southeast Asia Transthyretin Amyloidosis Treatment Market Forecast
10.3.5 India Transthyretin Amyloidosis Treatment Market Forecast
10.3.6 Australia Transthyretin Amyloidosis Treatment Market Forecast
10.4 Europe Transthyretin Amyloidosis Treatment Forecast by Country (2023-2028)
10.4.1 Germany Transthyretin Amyloidosis Treatment Market Forecast
10.4.2 France Transthyretin Amyloidosis Treatment Market Forecast
10.4.3 UK Transthyretin Amyloidosis Treatment Market Forecast
10.4.4 Italy Transthyretin Amyloidosis Treatment Market Forecast
10.4.5 Russia Transthyretin Amyloidosis Treatment Market Forecast
10.5 Middle East & Africa Transthyretin Amyloidosis Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Transthyretin Amyloidosis Treatment Market Forecast
10.5.2 South Africa Transthyretin Amyloidosis Treatment Market Forecast
10.5.3 Israel Transthyretin Amyloidosis Treatment Market Forecast
10.5.4 Turkey Transthyretin Amyloidosis Treatment Market Forecast
10.5.5 GCC Countries Transthyretin Amyloidosis Treatment Market Forecast
10.6 Global Transthyretin Amyloidosis Treatment Forecast by Type (2023-2028)
10.7 Global Transthyretin Amyloidosis Treatment Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Information
11.1.2 Pfizer Inc. Transthyretin Amyloidosis Treatment Product Offered
11.1.3 Pfizer Inc. Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc. Latest Developments
11.2 Johnson & Johnson Services, Inc.
11.2.1 Johnson & Johnson Services, Inc. Company Information
11.2.2 Johnson & Johnson Services, Inc. Transthyretin Amyloidosis Treatment Product Offered
11.2.3 Johnson & Johnson Services, Inc. Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Johnson & Johnson Services, Inc. Main Business Overview
11.2.5 Johnson & Johnson Services, Inc. Latest Developments
11.3 Ionis Pharmaceuticals, Inc.
11.3.1 Ionis Pharmaceuticals, Inc. Company Information
11.3.2 Ionis Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Product Offered
11.3.3 Ionis Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Ionis Pharmaceuticals, Inc. Main Business Overview
11.3.5 Ionis Pharmaceuticals, Inc. Latest Developments
11.4 Alnylam Pharmaceuticals, Inc.
11.4.1 Alnylam Pharmaceuticals, Inc. Company Information
11.4.2 Alnylam Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Product Offered
11.4.3 Alnylam Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Alnylam Pharmaceuticals, Inc. Main Business Overview
11.4.5 Alnylam Pharmaceuticals, Inc. Latest Developments
11.5 BridgeBio Pharma, Inc.
11.5.1 BridgeBio Pharma, Inc. Company Information
11.5.2 BridgeBio Pharma, Inc. Transthyretin Amyloidosis Treatment Product Offered
11.5.3 BridgeBio Pharma, Inc. Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 BridgeBio Pharma, Inc. Main Business Overview
11.5.5 BridgeBio Pharma, Inc. Latest Developments
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Information
11.6.2 Bristol-Myers Squibb Company Transthyretin Amyloidosis Treatment Product Offered
11.6.3 Bristol-Myers Squibb Company Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bristol-Myers Squibb Company Main Business Overview
11.6.5 Bristol-Myers Squibb Company Latest Developments
11.7 Acrotech Biopharma
11.7.1 Acrotech Biopharma Company Information
11.7.2 Acrotech Biopharma Transthyretin Amyloidosis Treatment Product Offered
11.7.3 Acrotech Biopharma Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Acrotech Biopharma Main Business Overview
11.7.5 Acrotech Biopharma Latest Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Transthyretin Amyloidosis Treatment Product Offered
11.8.3 AstraZeneca Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 AstraZeneca Main Business Overview
11.8.5 AstraZeneca Latest Developments
11.9 Astellas Pharma, Inc.
11.9.1 Astellas Pharma, Inc. Company Information
11.9.2 Astellas Pharma, Inc. Transthyretin Amyloidosis Treatment Product Offered
11.9.3 Astellas Pharma, Inc. Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Astellas Pharma, Inc. Main Business Overview
11.9.5 Astellas Pharma, Inc. Latest Developments
11.10 Prothena
11.10.1 Prothena Company Information
11.10.2 Prothena Transthyretin Amyloidosis Treatment Product Offered
11.10.3 Prothena Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Prothena Main Business Overview
11.10.5 Prothena Latest Developments
11.11 SOM Biotech
11.11.1 SOM Biotech Company Information
11.11.2 SOM Biotech Transthyretin Amyloidosis Treatment Product Offered
11.11.3 SOM Biotech Transthyretin Amyloidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 SOM Biotech Main Business Overview
11.11.5 SOM Biotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Transthyretin Amyloidosis Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of ATTR-PN
Table 3. Major Players of ATTR-CM
Table 4. Transthyretin Amyloidosis Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Transthyretin Amyloidosis Treatment Market Size Market Share by Type (2017-2022)
Table 7. Transthyretin Amyloidosis Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Transthyretin Amyloidosis Treatment Market Size Market Share by Application (2017-2022)
Table 10. Global Transthyretin Amyloidosis Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Player (2020-2022)
Table 12. Transthyretin Amyloidosis Treatment Key Players Head office and Products Offered
Table 13. Transthyretin Amyloidosis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Transthyretin Amyloidosis Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Transthyretin Amyloidosis Treatment Market Size Market Share by Regions (2017-2022)
Table 18. Americas Transthyretin Amyloidosis Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Transthyretin Amyloidosis Treatment Market Size Market Share by Country (2017-2022)
Table 20. Americas Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Transthyretin Amyloidosis Treatment Market Size Market Share by Type (2017-2022)
Table 22. Americas Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Transthyretin Amyloidosis Treatment Market Size Market Share by Application (2017-2022)
Table 24. APAC Transthyretin Amyloidosis Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Transthyretin Amyloidosis Treatment Market Size Market Share by Region (2017-2022)
Table 26. APAC Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Transthyretin Amyloidosis Treatment Market Size Market Share by Type (2017-2022)
Table 28. APAC Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Transthyretin Amyloidosis Treatment Market Size Market Share by Application (2017-2022)
Table 30. Europe Transthyretin Amyloidosis Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Transthyretin Amyloidosis Treatment Market Size Market Share by Country (2017-2022)
Table 32. Europe Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Transthyretin Amyloidosis Treatment Market Size Market Share by Type (2017-2022)
Table 34. Europe Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Transthyretin Amyloidosis Treatment Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Transthyretin Amyloidosis Treatment
Table 43. Key Market Challenges & Risks of Transthyretin Amyloidosis Treatment
Table 44. Key Industry Trends of Transthyretin Amyloidosis Treatment
Table 45. Global Transthyretin Amyloidosis Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Transthyretin Amyloidosis Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Transthyretin Amyloidosis Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Transthyretin Amyloidosis Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Transthyretin Amyloidosis Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Transthyretin Amyloidosis Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 51. Pfizer Inc. Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 52. Pfizer Inc. Transthyretin Amyloidosis Treatment Product Offered
Table 53. Pfizer Inc. Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Pfizer Inc. Main Business
Table 55. Pfizer Inc. Latest Developments
Table 56. Johnson & Johnson Services, Inc. Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 57. Johnson & Johnson Services, Inc. Transthyretin Amyloidosis Treatment Product Offered
Table 58. Johnson & Johnson Services, Inc. Main Business
Table 59. Johnson & Johnson Services, Inc. Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Johnson & Johnson Services, Inc. Latest Developments
Table 61. Ionis Pharmaceuticals, Inc. Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 62. Ionis Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Product Offered
Table 63. Ionis Pharmaceuticals, Inc. Main Business
Table 64. Ionis Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Ionis Pharmaceuticals, Inc. Latest Developments
Table 66. Alnylam Pharmaceuticals, Inc. Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 67. Alnylam Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Product Offered
Table 68. Alnylam Pharmaceuticals, Inc. Main Business
Table 69. Alnylam Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Alnylam Pharmaceuticals, Inc. Latest Developments
Table 71. BridgeBio Pharma, Inc. Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 72. BridgeBio Pharma, Inc. Transthyretin Amyloidosis Treatment Product Offered
Table 73. BridgeBio Pharma, Inc. Main Business
Table 74. BridgeBio Pharma, Inc. Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. BridgeBio Pharma, Inc. Latest Developments
Table 76. Bristol-Myers Squibb Company Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 77. Bristol-Myers Squibb Company Transthyretin Amyloidosis Treatment Product Offered
Table 78. Bristol-Myers Squibb Company Main Business
Table 79. Bristol-Myers Squibb Company Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Bristol-Myers Squibb Company Latest Developments
Table 81. Acrotech Biopharma Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 82. Acrotech Biopharma Transthyretin Amyloidosis Treatment Product Offered
Table 83. Acrotech Biopharma Main Business
Table 84. Acrotech Biopharma Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Acrotech Biopharma Latest Developments
Table 86. AstraZeneca Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 87. AstraZeneca Transthyretin Amyloidosis Treatment Product Offered
Table 88. AstraZeneca Main Business
Table 89. AstraZeneca Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. AstraZeneca Latest Developments
Table 91. Astellas Pharma, Inc. Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 92. Astellas Pharma, Inc. Transthyretin Amyloidosis Treatment Product Offered
Table 93. Astellas Pharma, Inc. Main Business
Table 94. Astellas Pharma, Inc. Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Astellas Pharma, Inc. Latest Developments
Table 96. Prothena Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 97. Prothena Transthyretin Amyloidosis Treatment Product Offered
Table 98. Prothena Main Business
Table 99. Prothena Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Prothena Latest Developments
Table 101. SOM Biotech Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 102. SOM Biotech Transthyretin Amyloidosis Treatment Product Offered
Table 103. SOM Biotech Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. SOM Biotech Main Business
Table 105. SOM Biotech Latest Developments
Table 1. Transthyretin Amyloidosis Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of ATTR-PN
Table 3. Major Players of ATTR-CM
Table 4. Transthyretin Amyloidosis Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Transthyretin Amyloidosis Treatment Market Size Market Share by Type (2017-2022)
Table 7. Transthyretin Amyloidosis Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Transthyretin Amyloidosis Treatment Market Size Market Share by Application (2017-2022)
Table 10. Global Transthyretin Amyloidosis Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Player (2020-2022)
Table 12. Transthyretin Amyloidosis Treatment Key Players Head office and Products Offered
Table 13. Transthyretin Amyloidosis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Transthyretin Amyloidosis Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Transthyretin Amyloidosis Treatment Market Size Market Share by Regions (2017-2022)
Table 18. Americas Transthyretin Amyloidosis Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Transthyretin Amyloidosis Treatment Market Size Market Share by Country (2017-2022)
Table 20. Americas Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Transthyretin Amyloidosis Treatment Market Size Market Share by Type (2017-2022)
Table 22. Americas Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Transthyretin Amyloidosis Treatment Market Size Market Share by Application (2017-2022)
Table 24. APAC Transthyretin Amyloidosis Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Transthyretin Amyloidosis Treatment Market Size Market Share by Region (2017-2022)
Table 26. APAC Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Transthyretin Amyloidosis Treatment Market Size Market Share by Type (2017-2022)
Table 28. APAC Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Transthyretin Amyloidosis Treatment Market Size Market Share by Application (2017-2022)
Table 30. Europe Transthyretin Amyloidosis Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Transthyretin Amyloidosis Treatment Market Size Market Share by Country (2017-2022)
Table 32. Europe Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Transthyretin Amyloidosis Treatment Market Size Market Share by Type (2017-2022)
Table 34. Europe Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Transthyretin Amyloidosis Treatment Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Transthyretin Amyloidosis Treatment
Table 43. Key Market Challenges & Risks of Transthyretin Amyloidosis Treatment
Table 44. Key Industry Trends of Transthyretin Amyloidosis Treatment
Table 45. Global Transthyretin Amyloidosis Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Transthyretin Amyloidosis Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Transthyretin Amyloidosis Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Transthyretin Amyloidosis Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Transthyretin Amyloidosis Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Transthyretin Amyloidosis Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 51. Pfizer Inc. Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 52. Pfizer Inc. Transthyretin Amyloidosis Treatment Product Offered
Table 53. Pfizer Inc. Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Pfizer Inc. Main Business
Table 55. Pfizer Inc. Latest Developments
Table 56. Johnson & Johnson Services, Inc. Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 57. Johnson & Johnson Services, Inc. Transthyretin Amyloidosis Treatment Product Offered
Table 58. Johnson & Johnson Services, Inc. Main Business
Table 59. Johnson & Johnson Services, Inc. Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Johnson & Johnson Services, Inc. Latest Developments
Table 61. Ionis Pharmaceuticals, Inc. Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 62. Ionis Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Product Offered
Table 63. Ionis Pharmaceuticals, Inc. Main Business
Table 64. Ionis Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Ionis Pharmaceuticals, Inc. Latest Developments
Table 66. Alnylam Pharmaceuticals, Inc. Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 67. Alnylam Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Product Offered
Table 68. Alnylam Pharmaceuticals, Inc. Main Business
Table 69. Alnylam Pharmaceuticals, Inc. Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Alnylam Pharmaceuticals, Inc. Latest Developments
Table 71. BridgeBio Pharma, Inc. Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 72. BridgeBio Pharma, Inc. Transthyretin Amyloidosis Treatment Product Offered
Table 73. BridgeBio Pharma, Inc. Main Business
Table 74. BridgeBio Pharma, Inc. Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. BridgeBio Pharma, Inc. Latest Developments
Table 76. Bristol-Myers Squibb Company Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 77. Bristol-Myers Squibb Company Transthyretin Amyloidosis Treatment Product Offered
Table 78. Bristol-Myers Squibb Company Main Business
Table 79. Bristol-Myers Squibb Company Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Bristol-Myers Squibb Company Latest Developments
Table 81. Acrotech Biopharma Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 82. Acrotech Biopharma Transthyretin Amyloidosis Treatment Product Offered
Table 83. Acrotech Biopharma Main Business
Table 84. Acrotech Biopharma Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Acrotech Biopharma Latest Developments
Table 86. AstraZeneca Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 87. AstraZeneca Transthyretin Amyloidosis Treatment Product Offered
Table 88. AstraZeneca Main Business
Table 89. AstraZeneca Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. AstraZeneca Latest Developments
Table 91. Astellas Pharma, Inc. Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 92. Astellas Pharma, Inc. Transthyretin Amyloidosis Treatment Product Offered
Table 93. Astellas Pharma, Inc. Main Business
Table 94. Astellas Pharma, Inc. Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Astellas Pharma, Inc. Latest Developments
Table 96. Prothena Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 97. Prothena Transthyretin Amyloidosis Treatment Product Offered
Table 98. Prothena Main Business
Table 99. Prothena Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Prothena Latest Developments
Table 101. SOM Biotech Details, Company Type, Transthyretin Amyloidosis Treatment Area Served and Its Competitors
Table 102. SOM Biotech Transthyretin Amyloidosis Treatment Product Offered
Table 103. SOM Biotech Transthyretin Amyloidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. SOM Biotech Main Business
Table 105. SOM Biotech Latest Developments
LIST OF FIGURES
LIST OF FIGURES
Figure 1. Transthyretin Amyloidosis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Transthyretin Amyloidosis Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Transthyretin Amyloidosis Treatment Market Size Market Share by Type in 2021
Figure 7. Transthyretin Amyloidosis Treatment in Hospital Pharmacies
Figure 8. Global Transthyretin Amyloidosis Treatment Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. Transthyretin Amyloidosis Treatment in Specialty Pharmacies
Figure 10. Global Transthyretin Amyloidosis Treatment Market: Specialty Pharmacies (2017-2022) & ($ Millions)
Figure 11. Transthyretin Amyloidosis Treatment in Retail Pharmacies
Figure 12. Global Transthyretin Amyloidosis Treatment Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 13. Transthyretin Amyloidosis Treatment in Online Pharmacies
Figure 14. Global Transthyretin Amyloidosis Treatment Market: Online Pharmacies (2017-2022) & ($ Millions)
Figure 15. Global Transthyretin Amyloidosis Treatment Market Size Market Share by Application in 2021
Figure 16. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Player in 2021
Figure 17. Global Transthyretin Amyloidosis Treatment Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Transthyretin Amyloidosis Treatment Market Size 2017-2022 ($ Millions)
Figure 19. APAC Transthyretin Amyloidosis Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Europe Transthyretin Amyloidosis Treatment Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size 2017-2022 ($ Millions)
Figure 22. Americas Transthyretin Amyloidosis Treatment Value Market Share by Country in 2021
Figure 23. Americas Transthyretin Amyloidosis Treatment Consumption Market Share by Type in 2021
Figure 24. Americas Transthyretin Amyloidosis Treatment Market Size Market Share by Application in 2021
Figure 25. United States Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Transthyretin Amyloidosis Treatment Market Size Market Share by Region in 2021
Figure 30. APAC Transthyretin Amyloidosis Treatment Market Size Market Share by Application in 2021
Figure 31. China Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Transthyretin Amyloidosis Treatment Market Size Market Share by Country in 2021
Figure 38. Europe Transthyretin Amyloidosis Treatment Market Size Market Share by Type in 2021
Figure 39. Europe Transthyretin Amyloidosis Treatment Market Size Market Share by Application in 2021
Figure 40. Germany Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Market Share by Application in 2021
Figure 48. Egypt Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 54. APAC Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 55. Europe Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 57. United States Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Canada Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 61. China Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Japan Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 63. Korea Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 65. India Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 66. Australia Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 67. Germany Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 68. France Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 69. UK Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Italy Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Russia Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 72. Spain Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 75. Israel Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
LIST OF FIGURES
Figure 1. Transthyretin Amyloidosis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Transthyretin Amyloidosis Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Transthyretin Amyloidosis Treatment Market Size Market Share by Type in 2021
Figure 7. Transthyretin Amyloidosis Treatment in Hospital Pharmacies
Figure 8. Global Transthyretin Amyloidosis Treatment Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. Transthyretin Amyloidosis Treatment in Specialty Pharmacies
Figure 10. Global Transthyretin Amyloidosis Treatment Market: Specialty Pharmacies (2017-2022) & ($ Millions)
Figure 11. Transthyretin Amyloidosis Treatment in Retail Pharmacies
Figure 12. Global Transthyretin Amyloidosis Treatment Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 13. Transthyretin Amyloidosis Treatment in Online Pharmacies
Figure 14. Global Transthyretin Amyloidosis Treatment Market: Online Pharmacies (2017-2022) & ($ Millions)
Figure 15. Global Transthyretin Amyloidosis Treatment Market Size Market Share by Application in 2021
Figure 16. Global Transthyretin Amyloidosis Treatment Revenue Market Share by Player in 2021
Figure 17. Global Transthyretin Amyloidosis Treatment Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Transthyretin Amyloidosis Treatment Market Size 2017-2022 ($ Millions)
Figure 19. APAC Transthyretin Amyloidosis Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Europe Transthyretin Amyloidosis Treatment Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size 2017-2022 ($ Millions)
Figure 22. Americas Transthyretin Amyloidosis Treatment Value Market Share by Country in 2021
Figure 23. Americas Transthyretin Amyloidosis Treatment Consumption Market Share by Type in 2021
Figure 24. Americas Transthyretin Amyloidosis Treatment Market Size Market Share by Application in 2021
Figure 25. United States Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Transthyretin Amyloidosis Treatment Market Size Market Share by Region in 2021
Figure 30. APAC Transthyretin Amyloidosis Treatment Market Size Market Share by Application in 2021
Figure 31. China Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Transthyretin Amyloidosis Treatment Market Size Market Share by Country in 2021
Figure 38. Europe Transthyretin Amyloidosis Treatment Market Size Market Share by Type in 2021
Figure 39. Europe Transthyretin Amyloidosis Treatment Market Size Market Share by Application in 2021
Figure 40. Germany Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size Market Share by Application in 2021
Figure 48. Egypt Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Transthyretin Amyloidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 54. APAC Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 55. Europe Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 57. United States Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Canada Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 61. China Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Japan Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 63. Korea Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 65. India Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 66. Australia Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 67. Germany Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 68. France Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 69. UK Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Italy Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Russia Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 72. Spain Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 75. Israel Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Transthyretin Amyloidosis Treatment Market Size 2023-2028 ($ Millions)
